HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 16,960
-300 (-1.74%)
At close: Jan 19, 2026
-35.02% (1Y)
| Market Cap | 238.16B |
| Revenue (ttm) | 36.10B |
| Net Income (ttm) | 472.66M |
| Shares Out | 14.04M |
| EPS (ttm) | 34.13 |
| PE Ratio | 503.87 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 132,893 |
| Average Volume | 127,272 |
| Open | 17,140 |
| Previous Close | 17,260 |
| Day's Range | 16,540 - 17,140 |
| 52-Week Range | 12,500 - 33,250 |
| Beta | 0.46 |
| RSI | 55.31 |
| Earnings Date | Mar 20, 2026 |